Browsing Category

66000 posts
Sisram Medical Announces 2023 Annual Results

Sisram Medical Announces 2023 Annual Results

Revenues of US$359.3M, with the direct sales portion reaching a record high…
Global Times: Xi's inspection tour in Hunan spotlights new quality productive forces, opening-up

Global Times: Xi's inspection tour in Hunan spotlights new quality productive forces, opening-up

BEIJING, March 20, 2024 /PRNewswire/ — Chinese President Xi Jinping made an inspection…
NEOM announces Treyam, its premier lagoon destination

NEOM announces Treyam, its premier lagoon destination

NEOM, Kingdom of Saudi Arabia, March 20, 2024 /PRNewswire/ — NEOM’s Board…
Acoustic Announces Global Acoustic Connect(SM) Momentum, Increased Talent Investments as Demand for Real-Time Customer Engagement Rises

Acoustic Announces Global Acoustic Connect(SM) Momentum, Increased Talent Investments as Demand for Real-Time Customer Engagement Rises

As Acoustic Connect℠ gains traction, Acoustic unveils global hiring initiatives and expanded…
A Groundbreaking Decision Framework for the United States Air Force's (USAF) Air Mobility Command (AMC)

A Groundbreaking Decision Framework for the United States Air Force's (USAF) Air Mobility Command (AMC)

WASHINGTON, March 20, 2024 /PRNewswire/ — Systecon North America utilizes a transformative…
Antengene Initiates Phase II Dose Expansion Study of Claudin 18.2 ADC ATG-022 in China and Australia

Antengene Initiates Phase II Dose Expansion Study of Claudin 18.2 ADC ATG-022 in China and Australia

SHANGHAI and HONG KONG, March 20, 2024 /PRNewswire/ — Antengene Corporation Limited…
The Digital Cockpit Domain Controller is Rapidly Gaining Popularity with Auto OEMs, Reaching 45 Million Shipments by 2030

The Digital Cockpit Domain Controller is Rapidly Gaining Popularity with Auto OEMs, Reaching 45 Million Shipments by 2030

LONDON, March 20, 2024 /PRNewswire/ — Quickening innovation across the entire technology…
Antennova Completes First Dosing Cohort for Anti-CD24 mAb, ATN-031, in the Phase I PERFORM Study

Antennova Completes First Dosing Cohort for Anti-CD24 mAb, ATN-031, in the Phase I PERFORM Study

ATN-031 (also known as ATG-031), is the first anti-CD24 antibody to advance…